Nkgen Biotech宣布国际和美国扩展1/2a troculeucel阿尔茨海默氏症的试验，并激活了加拿大和佛罗里达州的临床站点
SANTA ANA, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development…